Avid Bioservices (CDMO) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Avid Bioservices (CDMO) PT Raised to $11 at H.C. Wainwright
September 11, 2018 7:12 AM EDTH.C. Wainwright analyst Joseph Pantginis raised the price target on Avid Bioservices (NASDAQ: CDMO) to $11.00 (from $6.00) while maintaining a Buy rating.
Pantginis commented, "Yesterday, CDMO reported F1Q19 results, posting EPS of ($0.06), compared with our estimate of ($0.01) and consensus of ($0.13). Revenue for the first quarter was $12.58 million compared with our estimate of $12.87 million and consensus of $8.96 million. Avid ended the quarter with $37.5 million in cash. Management reaffirmed its F2019 revenue guidance of $51-55 million. Under... More
